Targeted Hypoglossal Neurostimulation Study #2
Completed · Not applicable
Conditions studied: Sleep Apnea Syndromes, Sleep Apnea, Obstructive, Respiration Disorders, Signs and Symptoms, Respiratory, Syndrome, Obstructive Sleep Apnea
In brief
The objective of the study is to confirm the safety and efficacy in patients utilizing the aura6000 System for the treatment of Obstructive Sleep Apnea (OSA).
Key facts
- Study ID
- NCT01796925
- Run by
- ImThera Medical, Inc.
- People needed
- 57
- Starts
- 2013-02-01
- Expected to finish
- 2014-09-01
- Last updated by the study team
- 2019-08-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- AHI >20
- Noncompliant to CPAP
- Willing to provide informed consent
- Willing to comply with all follow-up visits and evaluations
You may not qualify if…
- BMI limits
- COPD
- Central Sleep Apnea
- Anatomic variations interfering with device placement or stability.
Where it is running
- Sharp Rees Stealy Medical Center — San Diego, California, United States
- Porter Adventist Hospital — Denver, Colorado, United States
- Chicago ENT — Chicago, Illinois, United States
- Orange Regional Medical Center — Middletown, New York, United States
- Clinique Univ. Saint-Luc — Brussels, Belgium
- Pitié-Salpêtrière Hospital — Paris, France
- Advanced Sleep Research — Berlin, Germany
- St. Joseph-Stift — Bremen, Germany
- G.B. Morgagni- L. Pierantoni Hospital — Forlì, Italy
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.